Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management

    April 2023 in “ International Journal of Molecular Sciences ”
    Khaled S. Allemailem, Saleh A. Almatroodi, Ahmad Almatroudi … Amjad Ali Khan
    Studysummary This review discusses advances in CRISPR/Cas9 variants and nanoformulations for cancer treatment, noting challenges and prospects for clinical application, but reports no new research results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Stimuli-Responsive Nanoformulations for CRISPR-Cas9 Genome Editing Journal of Nanobiotechnology · 2022
    2. Spatiotemporal Control of CRISPR/Cas9 Gene Editing Signal Transduction and Targeted Therapy · 2021
    3. Ultrasound-Activated Particles as CRISPR/Cas9 Delivery System for Androgenic Alopecia Therapy Biomaterials · 2019